Search For "dcgi"
Updated : 7 months, 2 weeks ago IST
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
Updated : 8 months, 1 week ago IST
Hyderabad (Telangana) [India], Feb 19 (ANI): Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine candidate Sputnik V.
Bengaluru (Karnataka) [India], February 16 (ANI/PNN): A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce testing kits and diagnostic solutions that are made in India for use in India.
Updated : 8 months, 3 weeks ago IST
New Delhi [India] February 5 (ANI): The subject expert panel of Drugs Controller General of India did not recommend granting emergency use authorisation to Pfizer's COVID-19 vaccine noting that the firm has not proposed plans to generate safety and immunogenicity data concerning Indian popu
Pune (Maharashtra) [India], February 4 (ANI/PRNewswire): Recently Enzene Biosciences Ltd. announced that it has obtained Marketing Authorisation (MA) from Drug Controller General of India (DCGI) for Teriparatide - bioactive part of human parathyroid hormone (PTH), an anabolic approach to the
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci
Updated : 8 months, 4 weeks ago IST
New Delhi [India], January 28 (ANI): India's drug regulatory body has received requests from both Pune based Serum Institute of India and Hyderabad-based Bharat Biotech to make necessary changes in the vaccine fact sheet to allow people using blood thinners to get inoculated against Covid-19
Updated : 9 months, 2 weeks ago IST
Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
New Delhi [India], January 8 (ANI): The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday.
Updated : 9 months, 3 weeks ago IST
New Delhi [India], January 5 (ANI): Days after Drugs Controller General of India (DCGI) gave approval to two COVID-19 vaccines, Union Health Secretary Rajesh Bhushan on Tuesday said that India is prepared to roll out vaccine within 10 days of emergency use authorisation (EUA), subject to
New Delhi [India], January 5 (ANI): With Drugs Controller General of India (DCGI) approving two vaccine candidates in India, the Kazakhstan Ambassador to India Yerlan Alimbayev said that Kazakhstan will discuss the matter with India and is ready to procure the vaccines.
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr